Imperial College Genetic Therapies Centre, Department of Chemistry, Imperial College London, London, UK.
J Drug Target. 2013 Aug;21(7):684-92. doi: 10.3109/1061186X.2013.805336. Epub 2013 Jun 18.
The decoration of nanoparticle surfaces with receptor-specific ligands can improve the delivery of their therapeutic load to cancer cells. Using as the ligand, U11, a peptide specific for the cancer-associated urokinase plasminogen activator receptor, we examined the effect of manipulation of nanoparticle properties on the targeting specificity of U11-nanoparticles. The nanoparticle surface charge was controlled by varying the amount of the cationic lipid within the nanoparticle formulation. A reduction in surface charge led to an increase in the targeting effect of U11-nanoparticles, a result of limiting its non-specific interactions with negatively charged cellular membranes. Furthermore, fluorescence and circular dichroism spectroscopy were used to probe changes in the U11 presentation on the surfaces of nanoparticles. Optimized ligand conformations were when ligands were separated into monomers and protruded from the nanoparticle surface. It is concluded that both the ligand organization as well as the nanoparticle platform require control to give optimal cell uptake efficiencies.
通过将受体特异性配体修饰到纳米颗粒表面,可以改善其治疗负荷递送到癌细胞的效果。我们使用一种针对癌症相关尿激酶纤溶酶原激活物受体的特异性肽 U11 作为配体,研究了纳米颗粒性质的调控对 U11-纳米颗粒靶向特异性的影响。通过改变纳米颗粒配方中阳离子脂质的量来控制纳米颗粒表面电荷。表面电荷的降低导致 U11-纳米颗粒靶向效果的增加,这是由于限制了其与带负电荷的细胞膜的非特异性相互作用。此外,荧光和圆二色性光谱被用于探测 U11 在纳米颗粒表面呈现的变化。当配体分离成单体并从纳米颗粒表面突出时,U11 的呈现得到了优化。可以得出结论,为了获得最佳的细胞摄取效率,不仅需要控制配体的组织,还需要控制纳米颗粒平台。